Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Telemedicine and artificial intelligence to support self-isolation of COVID-19 patients: Recent updates and challenges.

Authors:
Jessica A Huang Intan R Hartanti Michelle N Colin Dian Ae Pitaloka

Digit Health 2022 Jan-Dec;8:20552076221100634. Epub 2022 May 15.

Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.

Background: Asymptomatic and high-risk COVID-19 patients are advised to self-isolate at home. However, patients may not realize that the condition is deteriorating until too late.

Objective: This study aims to review various artificial intelligence-based telemedicine research during the COVID-19 outbreak and proposes a framework for developing telemedicine powered by artificial intelligence to monitor progression in COVID-19 patients during isolation at home. It also aims to map challenges using artificial intelligence-based telemedicine in the community.

Methods: A systematic review was performed for the related articles published in 2019-2021 and conducted in the PubMed and ScienceDirect database using the keywords "telemedicine," "artificial intelligence," and "COVID-19". The inclusion criteria were full-text articles and original research written in the English language.

Results: Thirteen articles were included in this review to describe the current application of artificial intelligence-based telemedicine during the COVID-19 pandemic. Various current applications have been implemented, such as for early diagnosis and tracing of contact for the users, to monitor symptoms and decision-making treatment, clinical management, and virtual and remote treatment. We also proposed the framework of telemedicine powered by artificial intelligence for support the self-isolation of COVID-19 patients based on the recent update in technology. However, we identified some challenges for using digital health technologies because of the ethical and practical use, the policy and regulation, and device use both for healthcare workers and patients.

Conclusion: Artificial intelligence promises to improve the practice of medicine in various ways. However, practical applications still need to be explored, and medical professionals also need to adapt to these advances for better healthcare delivery to the public.

Download full-text PDF

Source
http://dx.doi.org/10.1177/20552076221100634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118431PMC
May 2022

Publication Analysis

Top Keywords

covid-19 patients
16
artificial intelligence
16
artificial intelligence-based
12
intelligence-based telemedicine
12
powered artificial
8
telemedicine powered
8
intelligence support
8
telemedicine covid-19
8
support self-isolation
8
self-isolation covid-19
8
artificial
6
telemedicine
6
covid-19
6
patients
5
early diagnosis
4
application artificial
4
covid-19 pandemic
4
pandemic current
4
current applications
4
applications implemented
4

Keyword Occurance

Similar Publications

Improving the Telemedicine Evaluation of Patients With Acute Vision Loss: A Call to Eyes.

Authors:
Stephen English Kevin M Barrett William D Freeman Bart M Demaerschalk Oana Dumitrascu

Neurology 2022 Jun 28. Epub 2022 Jun 28.

Departments of Neurology and Ophthalmology, Mayo Clinic College of Medicine and Science, Phoenix, Arizona.

Acute vision loss related to cerebral or retinal ischemia is a time-sensitive emergency with potential treatment options including intravenous or intraarterial thrombolysis and mechanical thrombectomy. However, patients either present in delayed fashion or present to an emergency department that lacks the subspecialty expertise to recognize and treat these conditions in a timely fashion. Moreover, healthcare systems in the United States are becoming increasingly reliant on telestroke and teleneurology services for acute neurologic care, making accurate diagnosis of acute vision loss even more challenging due to critical limitations to the remote video evaluation, including the inability to perform routine ophthalmoscopy. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2-Recovered Dialysis Patients.

Authors:
Philippe Attias Imane Azzaoui Khalil El Karoui Andréa de La Selle Aurélien Sokal Pascal Chappert Philippe Grimbert Ignacio Fernandez Magali Bouvier Chloé Samson Djamal Dahmane Philippe Rieu Patrice Nizard Slim Fourati Hamza Sakhi Matthieu Mahévas

Clin J Am Soc Nephrol 2022 Jun 28. Epub 2022 Jun 28.

Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Department of Nephrology, Centre de Référence Maladie Rare Syndrome Néphrotique Idiopathique, Fédération Hospitalo-Universitaire Innovative Therapy for Immune Disorders, Creteil, France.

Background And Objectives: After two doses of mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients on dialysis show a defective humoral response, but a third dose could increase anti-SARS-CoV-2 spike IgG titers. Responses could be different in virus-naive and SARS-CoV-2-recovered patients on dialysis. However, characterization of memory B cell response after three doses is lacking. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Influenza activity in the Eastern Mediterranean Region (EMR) in 2020-2021 amidst the COVID-19 pandemic.

Authors:
Hala Abou El Naja Stefano Tempia Amal Barakat Amgad Elkholy Amir Aman Wasiq Khan Abdinasir Abubakar

BMJ Glob Health 2022 Jun;7(Suppl 4)

Infectious Hazard Prevention and Preparedness, World Health Organization- Eastern Mediterranean Regional Office, Cairo, Egypt

Introduction: A global reduction in influenza virus activity during the COVID-19 pandemic has been observed, including in the Eastern Mediterranean Region (EMR). However, these changes have not been thoroughly evaluated scientifically in the EMR.

Objective: We aim to present data on seasonal influenza activity during the pre-pandemic period (2016-2019) and compare it to the pandemic period (2020-2021) in EM countries. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Predictors of Respiratory Support Use in Emergency Department Patients With COVID-19-Related Respiratory Failure.

Authors:
Neha N Goel Erin Eschbach Daniel McConnell Bryan Beattie Sean Hickey John Rozehnal Evan Leibner Gary Oldenburg Kusum S Mathews

Respir Care 2022 Jun 28. Epub 2022 Jun 28.

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Background: Given the known downstream implications of choice of respiratory support on patient outcomes, all factors influencing these decisions, even those not limited to the patient, warrant close consideration. We examined the effect of emergency department (ED)-specific system factors, such as work load and census, on the use of noninvasive versus invasive respiratory support.

Methods: We conducted a multi-center retrospective cohort study of all adult subjects with severe COVID-19 requiring an ICU admission from 5 EDs within a single urban health care system. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19.

Authors:
Mirko Scordio Federica Frasca Letizia Santinelli Leonardo Sorrentino Alessandra Pierangeli Ombretta Turriziani Claudio M Mastroianni Guido Antonelli Raphael P Viscidi Gabriella d'Ettorre Carolina Scagnolari

Clin Immunol 2022 Jun 25:109068. Epub 2022 Jun 25.

Department of Molecular Medicine, Laboratory of Virology, Sapienza University of Rome, Viale di Porta Tiburtina n° 28, 00185 Rome, Italy. Electronic address:

The presence of anti-IFN neutralizing antibodies (NAB) has been reported in critically ill COVID-19 patients. We found that 87.5% (7/8) of HIV-1 patients co-infected with SARS-CoV-2 had serum anti-IFN-I NAB against IFN-α subtypes, IFN-β and/or IFN-ω. Read More

View Article and Full-Text PDF
June 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap